8:22 AM
Leo Group India
| ||
| Sun Pharma to acquire DUSA Pharmaceuticals Express Pharma Sun Pharmaceutical Industries and DUSA Pharmaceuticals have announced that they have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan ... See all stories on this topic » | ||
| Frost & Sullivan: Lack of Proper Price Regulation for Pharmaceuticals Sacramento Bee CAPE TOWN, South Africa, Nov. 12, 2012 -- /PRNewswire/ -- Given the high burden of Sub-Saharan Africa's infectious diseases, improvements in healthcare systems are crucial to addressing these underlying issues. A lack of proper price regulations for ... See all stories on this topic » | ||
| Croatia arrests pharma staff, doctors in bribery case Reuters ZAGREB Nov 12 (Reuters) - Croatia's anti-corruption police have arrested the management of a local pharmaceutical firm and dozens of doctors on suspicion of bribery over the prescription of medicines, officials said on Monday. The former Yugoslav ... See all stories on this topic » | ||
| OASMIA PHARMACEUTICAL AB : Preliminary result of Oasmia's rights issue 4-traders The subscription period for Oasmia Pharmaceutical AB's (publ) ("Oasmia" or the "Company") rights issue ended on November 9, 2012. The preliminary result of the rights issue indicates that 18,201,726 shares, representing approximately 74 per cent of the ... See all stories on this topic » | ||
| BIOCRYST PHARMACEUTICALS, INC. : BioCryst Broad-Spectrum Antiviral ... 4-traders BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced proof-of-principle data demonstrating that BCX4430 is efficacious and well tolerated in a preclinical disease model for evaluating efficacy against yellow fever virus infection. BCX4430 is ... See all stories on this topic » | ||
| Bank of America Analysts Begin Coverage on Intercept Pharmaceuticals (ICPT) Daily Political The analysts wrote, "We are initiating coverage of Intercept pharmaceuticals (ICPT) with a Buy rating and DCF derived $29 PO. ICPT is a development stage pharmaceutical company focused on bile acid derived therapeutics. The company's lead product is ... See all stories on this topic » | ||
| Fabrice Egros has Been Appointed COO, Pharmaceutical Director and Board ... The Herald | HeraldOnline.com MOSCOW — Fabrice Egros was appointed as COO, Pharmaceutical Director and board member of NovaMedica, a novel Russian pharmaceutical company, which was established within the frameworks of the joint project between RUSNANO and the ... See all stories on this topic » | ||
| Investment contracts with pharmaceutical companies to be signed at Belarus ... News of Belarus MINSK, 12 November (BelTA) – There are plans to sign investment contracts with companies specializing in manufacturing energy-effective equipment and pharmaceuticals. The information was released by Mr Dmitry Klevzhits, Director of the National ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment